EU: ABEL TIE?? [Two-Stage / GS Designs]

posted by mittyri – Russia, 2019-10-19 23:24 (946 d 21:24 ago) – Posting: # 20707
Views: 3,407

Hi Helmut,

» an update: Yesterday at the 4th Biosimilars Forum a participant asked whether simulation-based methods (control of the type I error in a sufficiently high number of simulations, i.e., 1 mio in each cell of a narrow grid of n1/CV combinations) are acceptable. Andreas Brandt (BfArM and observer at the BSWP) answered “No.”

sad story
BTW: in your lecture you suggested to adjust the CIs for ABEL due to TIE inflation. Is that also dead?
Does it mean that you cannot prove anything using sims??

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,092 posts in 4,630 threads, 1,567 registered users;
online 12 (0 registered, 12 guests [including 12 identified bots]).
Forum time: Monday 20:48 CEST (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5